NeurologyLive Friday 5 — May 1, 2020


Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 1, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: David Langer, MD: Answering the Call for COVID-19

The chair of neurosurgery at Lenox Hill Hospital in Manhattan recently joined the ranks of health care providers who are caring for COVID-19 patients at the temporary hospital set up in the Javits Center.


2: AAN 2020: Ubrogepant More Effective in Mild Pain Migraine Attacks

Allergan’s oral CGRP antagonist showed a higher likelihood of freedom from pain and associated symptoms during mild headaches for patients with migraine compared to attacks of moderate to severe severity.


3: COViMS Registry Sheds Light on MS Patients With COVID-19

The Rosenthal—Trotter MS Chair in Neuroimmunology at Washington University School of Medicine in St. Louis details why the COViMS registry can serve as an important instrument for clinicians who treat patients with multiple sclerosis.


4: Peer Exchange: Overview of Spinal Muscular Atrophy

Crystal Proud, MD, leads a virtual panel discussion on spinal muscular atrophy, including the signs and symptoms that lead to a diagnosis.


5: Jennifer Frontera, MD: Neurologic Symptoms of COVID-19

The professor of neurology at NYU Langone detailed the neurologic symptoms that have been observed in patients with COVID-19.


Related Videos
Ava L. Liberman, MD, medical director of the Stroke Center at Weill Cornell Medicine
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
Tudor Jovin, MD; Lauren Sansing, MD, MS, FAHA
Anne W. Alexandrov PhD, RN, CCRN, ANVP-BC, NVRN-BC, FAAN
Annabel Sorby-Adams, PhD
© 2024 MJH Life Sciences

All rights reserved.